Cognitalis mission is to support its customer's drug discovery programs through drug design.

The company was founded in 2004 and has its premises in Valencia, Spain. Cognitalis offers its powerful pharmacoinformatics based technological platform and unique know-how allowing pharmaceutical companies to streamline their discovery process, help them to maximise their resources and save their research costs.

Cognitalis develops proprietary entirely new approaches in computer-aided drug design. These programs are not intended to be commercialised; they constitute one important component of the company's unique potential.

Cognitalis brings a new dimension to drug discovery through its state-of-the-art technologies.

Our aim is to become the partner of choice to establish long-term relationships with our customers, their goals become our goals and their success becomes our success.